Montreal, February 27, 2026 – A group of MyCBDR users will have received an email in recent days inviting them to complete the PROBE survey....
Montreal, February 5, 2026 – Four Canadian bleeding disorder treatment centres are participating in the Phase 1 clinical trial of Regeneron’s CRISPR/Cas9-based targeted gene insertion...
The call for applications for the CHS’ research programs for the 2026-2027 grant period is ongoing. The deadline to submit applications for all the programs...
PREAMBLE We have already come to the end of this important series of articles about the national board and operational committees on which our volunteers...
As a youth delegate representing Canada at the WFH 2024 World Congress, I found myself among experienced professionals, leaders of national hemophilia chapters, health care...